Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Jamaica
(0/week)
Netherlands Antilles
(0/week)
View all
(0/week)
News
United States
(1405/week)
Manufacturing
(646/week)
Energy
(481/week)
Technology
(1196/week)
Other Manufacturing
(460/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Synthetic opioids
Oct 03, 2018
New study finds that using fentanyl test strips can lead to safer drug use behaviors
Aug 31, 2018
Upsher-Smith Launches Generic Version of Lomotil® (diphenoxylate hydrochloride and atropine sulfate tablets)
Aug 16, 2018
Plausible Link Between Epidural Drug and Fentanyl Addiction Published in Medical Hypotheses
Aug 01, 2018
Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA's continued, careful oversight of the REMS associated with transmucosal immediate-release fentanyl products
Jul 24, 2018
VUV Analytics Hosting Executive Roundtable on Novel Approaches in Combating the Opioid Crisis and Designer Drug Abuse on the East Coast
May 29, 2018
Fire Service Fights Back Against the Opioid Epidemic
Apr 16, 2018
Alkermes Announces FDA Acceptance for Review of New Drug Application for ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder
Apr 03, 2018
Dr. Ottavio Vitolo Joins Relmada Therapeutics as Senior Vice President, Head of R&D and Chief Medical Officer
Apr 02, 2018
Alkermes Receives Refusal to File Letter From FDA for ALKS 5461
Feb 14, 2018
DQE Sentry Shield(TM) Powdered Substance Protection Kits Delivers Hazardous Opioid Exposure Protection
Feb 09, 2018
ProfNet Experts Available on OTC Anti-Diarrhea Products, Health System Reform, More
Jan 31, 2018
Alkermes Submits New Drug Application To U.S. FDA For ALKS 5461 For The Adjunctive Treatment Of Major Depressive Disorder
Jan 30, 2018
Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to help prevent new addiction, curb abuse and overdose related to opioid products
Jan 17, 2018
Relmada Therapeutics Acquires Global Rights to Develop and Market Dextromethadone for Treatment of Disorders of the Nervous System
Jan 09, 2018
Relmada Therapeutics Announces Notice of Acceptance of Key Patent in Europe Covering NMDA Receptor Antagonist d-Methadone for Treatment of Psychiatric Symptoms
Dec 21, 2017
TFAH Analysis: New Data Shows Drug Overdoses Increased in 40 States and Washington, D.C.
Dec 18, 2017
Statement from the Co-Chairs of Special Advisory Committee on the Epidemic of Opioid Overdoses on Updates to Opioid-Related Mortality Data
‹‹
Page 2
Latest News
Aug 14, 2025
Spartan Emergency Response Breaks Ground on $20 Million Facility Expansion to Increase Production
Aug 14, 2025
Alliance Resource Partners, L.P. Announces the Promotion of Jesse M. Parrish to Sr. Vice President and Chief...
Aug 14, 2025
KBRA Downgrades Pennsylvania Turnpike Commission Oil Franchise Tax Senior Revenue Bonds to AA- and...
Aug 14, 2025
Kontrol Technologies Announces Second Quarter 2025 Financial Results
Aug 14, 2025
Halliburton Announces Dividend
Aug 14, 2025
Carlisle Companies Announces Pricing of Senior Notes Offering
Aug 14, 2025
Bioretec Ltd's Half-year report 2025: Strong support for future growth from a successful rights issue
Aug 14, 2025
Parents Urged to Make Kids' Bedtime Screen-Free as National Campaign Launches with NYC Flash Mob
View all News
Agenda
30
September
Portugal
Troia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United Kingdom
London, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events